Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
The Lancet. Oncology
|
December 5, 2024
Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatment
M Saiful Huq, Sandhya C Acharya, Susmita Sharma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K Park, J Vansteenkiste, K H Lee, et al.
The Lancet. Oncology
|
December 5, 2024
Cancer education and training within the South Asian Association for Regional Cooperation (SAARC) countries
M Saiful Huq, Sandhya C Acharya, Simit Sapkota, et al.
South Asian Journal of Cancer
|
March 24, 2025
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)
Purvish M Parikh, Ghanashyam Biswas, Nilesh Ashok Dhamne, et al.
The Lancet. Oncology
|
December 5, 2024
Cancer research in South Asian Association for Regional Cooperation (SAARC) countries
M Saiful Huq, Sandhya C Acharya, Manish Gautam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, et al.
The Lancet. Oncology
|
May 29, 2018
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy, Seock-Ah Im, Marco Colleoni, et al.
Clinical Lung Cancer
|
January 16, 2026
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Pascale Tomasini, Oscar Juan-Vidal, Raffaele Califano, et al.
ESMO Open
|
January 25, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
S Koppikar, A Oaknin, K Govind Babu, et al.
Journal of Global Oncology
|
August 8, 2018
National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer
Supriya J Chopra, Ashwathy Mathew, Amita Maheshwari, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
The Lancet. Oncology
|
December 5, 2024
Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatment
M Saiful Huq, Sandhya C Acharya, Susmita Sharma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K Park, J Vansteenkiste, K H Lee, et al.
The Lancet. Oncology
|
December 5, 2024
Cancer education and training within the South Asian Association for Regional Cooperation (SAARC) countries
M Saiful Huq, Sandhya C Acharya, Simit Sapkota, et al.
South Asian Journal of Cancer
|
March 24, 2025
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)
Purvish M Parikh, Ghanashyam Biswas, Nilesh Ashok Dhamne, et al.
The Lancet. Oncology
|
December 5, 2024
Cancer research in South Asian Association for Regional Cooperation (SAARC) countries
M Saiful Huq, Sandhya C Acharya, Manish Gautam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, et al.
The Lancet. Oncology
|
May 29, 2018
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy, Seock-Ah Im, Marco Colleoni, et al.
Clinical Lung Cancer
|
January 16, 2026
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Pascale Tomasini, Oscar Juan-Vidal, Raffaele Califano, et al.
ESMO Open
|
January 25, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
S Koppikar, A Oaknin, K Govind Babu, et al.
Journal of Global Oncology
|
August 8, 2018
National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer
Supriya J Chopra, Ashwathy Mathew, Amita Maheshwari, et al.
Page
of 12